Oct 12, 2026 04:03PM
Oct 12, 2026 04:00PM
Oct 2, 2026 07:30AM
Sep 30, 2026 07:31AM
Sep 30, 2026 07:30AM
Sep 17, 2026 04:00PM
Aug 31, 2026 06:05AM Cytokinetics aficamten shows cardiac benefits in two HCM trial analyses
Aug 29, 2026 10:30AM
Aug 28, 2026 05:51AM
Aug 28, 2026 05:45AM
Aug 20, 2026 07:30AM
Aug 18, 2026 04:00PM
Aug 6, 2026 04:00PM
Jul 30, 2026 06:21AM Cytokinetics wins UK approval for heart drug aficamten
Jul 30, 2026 06:20AM
Jul 23, 2026 04:00PM
Jul 17, 2026 04:00PM
Jul 7, 2026 07:30AM
Jun 17, 2026 04:00PM
Jun 8, 2026 07:30AM
Jun 1, 2026 07:32AM Cytokinetics launches MYQORZO in Germany, first EU market
Jun 1, 2026 07:30AM
May 27, 2026 04:00PM
May 20, 2026 04:00PM
May 18, 2026 04:00PM
May 14, 2026 07:30AM
May 12, 2026 04:00PM
May 11, 2026 10:08AM Cytokinetics presents new MYQORZO data at ESC Heart Failure 2026
May 11, 2026 10:06AM
May 5, 2026 04:05PM
May 5, 2026 07:30AM
May 5, 2026 07:30AM
May 4, 2026 04:00PM
May 4, 2026 04:00PM
Apr 28, 2026 07:31AM Cytokinetics announces nine presentations at heart failure conference
Apr 28, 2026 07:30AM
Apr 21, 2026 04:00PM
Apr 20, 2026 04:00PM
Apr 6, 2026 04:00PM
Mar 16, 2026 08:00AM
Mar 2, 2026 04:00PM
Feb 24, 2026 04:00PM Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update
Feb 17, 2026 07:38AM
Feb 17, 2026 07:30AM
Feb 12, 2026 04:00PM
Feb 9, 2026 07:30AM
Jan 27, 2026 08:00AM
Jan 27, 2026 07:32AM
Jan 27, 2026 07:30AM Cytokinetics Announces MYQORZO™ (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptom
Jan 20, 2026 04:00PM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All